Document is current
Any future updates will be listed below
-
Authors
Mielke, Johanna
Trucks-Jansen, Holger
Schurmann, Claudia
Kotsis, Fruzsina
Köttgen, Anna http://orcid.org/0000-0002-4671-3714
Schneider, Markus P.
Eckardt, Kai-Uwe http://orcid.org/0000-0003-3823-0920
,
Kotsis, Fruzsina
Köttgen, Anna
Schneider, Markus P.
Eckardt, Kai-Uwe http://orcid.org/0000-0003-3823-0920
Freitag, Daniel F.
Eitner, Frank
Becker, Michael S. http://orcid.org/0000-0001-5502-7444
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (NAKSYS)
Bundesministerium für Bildung und Forschung (01ZX1912B, 01ER0804)
KfH Foundation for Preventive Medicine and corporate sponsors.
- License Information
-
More Information
Article History
Received: 1 September 2021
Revised: 30 March 2022
Accepted: 21 April 2022
First Online: 9 May 2022
Competing interests
: JM, HT-J, CS, DFF, FE, MSB are employees from Bayer AG. For the remaining authors no conflicts of interest were declared.
: The study was approved by the local ethics committee, registered in the German national registry for clinical studies (DRKS00003971) and was conducted according to the principles of the Declaration of Helsinki and Good Clinical Practice. Informed consent was obtained from all patients prior to enrollment.
